Pitcairn’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$244K Sell
7,737
-1,396
-15% -$44K 0.02% 621
2025
Q1
$299K Buy
9,133
+166
+2% +$5.44K 0.02% 577
2024
Q4
$324K Buy
8,967
+149
+2% +$5.39K 0.02% 561
2024
Q3
$275K Sell
8,818
-1,033
-10% -$32.2K 0.02% 613
2024
Q2
$264K Buy
9,851
+668
+7% +$17.9K 0.02% 620
2024
Q1
$313K Buy
9,183
+109
+1% +$3.72K 0.02% 567
2023
Q4
$263K Sell
9,074
-75
-0.8% -$2.17K 0.02% 579
2023
Q3
$252K Buy
9,149
+521
+6% +$14.4K 0.02% 551
2023
Q2
$259K Sell
8,628
-64
-0.7% -$1.92K 0.02% 553
2023
Q1
$315K Sell
8,692
-176
-2% -$6.38K 0.03% 475
2022
Q4
$316K Sell
8,868
-333
-4% -$11.9K 0.03% 449
2022
Q3
$311K Buy
9,201
+150
+2% +$5.07K 0.03% 416
2022
Q2
$262K Buy
9,051
+52
+0.6% +$1.51K 0.03% 479
2022
Q1
$291K Buy
8,999
+523
+6% +$16.9K 0.03% 508
2021
Q4
$247K Buy
+8,476
New +$247K 0.02% 573
2018
Q3
Sell
-8,138
Closed -$487K 545
2018
Q2
$487K Sell
8,138
-724
-8% -$43.3K 0.05% 261
2018
Q1
$406K Buy
8,862
+392
+5% +$18K 0.04% 287
2017
Q4
$337K Buy
8,470
+273
+3% +$10.9K 0.03% 356
2017
Q3
$328K Sell
8,197
-40
-0.5% -$1.6K 0.04% 340
2017
Q2
$355K Sell
8,237
-731
-8% -$31.5K 0.04% 303
2017
Q1
$281K Sell
8,968
-337
-4% -$10.6K 0.03% 386
2016
Q4
$235K Sell
9,305
-2,219
-19% -$56K 0.03% 437
2016
Q3
$285K Sell
11,524
-403
-3% -$9.97K 0.04% 384
2016
Q2
$243K Sell
11,927
-424
-3% -$8.64K 0.03% 383
2016
Q1
$189K Buy
+12,351
New +$189K 0.02% 449